Type 2 drug does not increase heart events
Dulaglutide does not increase the risk of major cardiovascular (CV) events in people with type 2 diabetes, research has found. The meta-analysis evaluated the CV risk in people with the ...
Dulaglutide does not increase the risk of major cardiovascular (CV) events in people with type 2 diabetes, research has found. The meta-analysis evaluated the CV risk in people with the ...
Incidents of serious diabetic ketoacidosis (DKA) cases in people who have been taking sodium-glucose co-transporter-2 (SGLT2) have been reported where people’s blood sugar levels have not ...
A leading diabetes charity has issued a warning at the start of the Chinese New Year for the Chinese community to check their risk of type 2 diabetes. Chinese people are one of the ethnic groups ...
People with type 2 diabetes are 60 per cent more likely to develop dementia, a study has suggested. The research, which involved 2.5 million participants and an international team of scientists, ...
The NHS should offer weight loss surgery to thousands more people in order to tackle an epidemic of Type 2 diabetes, according to health watchdog NICE. NICE is recommending all patients with a ...